^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
iCasp9M28z T cell infusion
i
Other names: iCasp9M28z T cell infusion, genetically engineered anti-mesothelin autologous T cells
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Bellicum, Memorial Sloan-Kettering Cancer Center
Drug class:
Mesothelin-targeted CAR-T immunotherapy
Related drugs:
